Cite
HARVARD Citation
Guerrero, J. et al. (2013). Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration‐resistant prostate cancer. Prostate. 73 (12), pp. 1291-1305. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guerrero, J. et al. (2013). Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration‐resistant prostate cancer. Prostate. 73 (12), pp. 1291-1305. [Online].